Log in

NASDAQ:BMRNBioMarin Pharmaceutical Earnings Date, Estimates & History

$119.83
0.00 (0.00 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$118.76
Now: $119.83
$124.52
50-Day Range
$106.47
MA: $123.87
$131.03
52-Week Range
$62.88
Now: $119.83
$131.95
Volume1.38 million shs
Average Volume1.05 million shs
Market Capitalization$21.67 billion
P/E Ratio181.56
Dividend YieldN/A
Beta1.05

Earnings

BioMarin Pharmaceutical (NASDAQ:BMRN) Earnings Information

BioMarin Pharmaceutical last posted its earnings results on April 29th, 2020. The biotechnology company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.32. The firm earned $502.07 million during the quarter, compared to the consensus estimate of $468.77 million. Its revenue was up 25.3% on a year-over-year basis. BioMarin Pharmaceutical has generated $0.07 earnings per share over the last year and currently has a price-to-earnings ratio of 181.6. BioMarin Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 28th, 2020 based off prior year's report dates.

BioMarin Pharmaceutical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BioMarin Pharmaceutical (NASDAQ:BMRN) Earnings Estimates

2020 EPS Consensus Estimate: $0.56
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203$0.07$0.16$0.13
Q2 20207($0.17)$0.37$0.14
Q3 20204$0.07$0.24$0.17
Q4 20205($0.03)$0.32$0.12
Q1 20211$0.43$0.43$0.43
Q2 20211$0.26$0.26$0.26
Q4 20211$0.43$0.43$0.43

BioMarin Pharmaceutical (NASDAQ BMRN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
10/28/2020
(Estimated)
       
4/29/2020Q1 20$0.12$0.44$0.32$468.77 million$502.07 millionTranscript
2/26/2020Q4$0.01$0.08$0.10$461.88 million$454.44 millionTranscript
10/23/2019Q3$0.06$0.31$0.14$455.78 million$461.10 millionTranscript
8/1/2019Q2 2019($0.05)($0.21)$0.05$415.03 million$388.00 millionListen
4/25/20193/31/2019($0.12)($0.10)$0.12$389.95 million$400.70 millionTranscript
2/21/201912/31/2018($0.09)($0.02)($0.53)$377.35 million$353.00 millionListen
10/25/20189/30/2018($0.22)($0.07)($0.07)$369.43 million$391.71 millionTranscript
8/2/2018Q2 2018($0.06)($0.09)($0.01)$359.25 million$372.80 millionN/A
4/25/2018Q1 2018($0.17)($0.25)$0.10$348.73 million$373.45 millionN/A
2/22/2018Q4 2017($0.24)($0.30)($0.30)$346.24 million$358.31 millionN/A
10/26/2017Q3 2017($0.13)($0.07)($0.07)$347.38 million$334.18 millionN/A
8/2/2017Q2 2017($0.22)($0.21)$0.11$311.41 million$317.50 millionListen
5/4/2017Q1 2017($0.30)$0.03$0.15$292.58 million$303.70 millionListen
2/23/2017Q416($0.38)($0.53)($0.21)$296.54 million$300.00 millionN/A
10/27/2016Q3 2016($0.39)($0.26)($0.26)$289.70 million$279.90 millionListen
8/4/2016Q216($0.52)($2.61)$2.39$278.75 million$300.10 millionN/A
4/28/2016Q116($0.85)($0.53)($0.17)$240.21 million$236.70 millionListen
2/25/2016Q415$0.67$0.39($1.55)$224.14 million$227.90 millionListen
10/29/2015Q315($0.65)($0.60)($0.60)$216.32 million$208.90 millionListen
8/3/2015Q215($0.53)($0.22)$0.07$218.16 million$250.50 millionN/A
4/30/2015Q1($0.53)($0.25)($0.07)$204.58 million$203.26 millionN/A
2/25/2015Q414($0.59)($0.30)($0.13)$189.01 million$230.90 millionN/A
10/23/2014Q314($0.22)($0.16)($0.37)$206.00 million$176.80 millionListen
7/30/2014Q214($0.42)($0.19)($0.15)$159.70 million$191.70 millionN/A
5/1/2014Q1 2014($0.50)($0.27)($0.27)$145.16 million$151.60 millionN/A
2/26/2014Q4 2013($0.34)($0.27)($0.11)$146.07 million$146.90 millionN/A
10/24/2013Q3 2013($0.28)($0.38)($0.38)$140.00 million$136.90 millionTranscript
7/25/2013Q2 2013($0.28)($0.16)($0.16)$134.33 million$136.80 millionListen
4/25/2013Q1 2013($0.28)($0.31)($0.31)$131.35 million$127.90 millionN/A
2/21/2013Q4 2012($0.22)($0.43)$129.70 million$130.96 millionN/A
10/25/2012($0.20)($0.04)N/A
8/1/2012($0.19)($0.27)N/A
4/26/2012($0.15)($0.21)N/A
2/16/2012($0.10)($0.23)Transcript
10/27/2011($0.10)($0.16)N/A
7/28/2011($0.09)($0.05)N/A
4/28/2011($0.10)$0.14N/A
2/17/2011($0.02)($0.11)Transcript
10/28/2010Q3 2010($0.02)($0.03)($1.74)N/A
8/2/2010Q2 2010$0.02($0.01)($0.01)N/A
4/29/2010Q1 2010$0.01$0.01N/A
2/23/2010Q4 2009$0.05$0.05N/A
10/28/2009Q3 2009$0.06$0.06N/A
4/30/2009Q1 2009($0.12)($0.13)($0.13)N/A
2/18/2009Q4 2008$0.24$0.24$0.27N/A
10/28/2008Q3 2008$0.03$0.01$0.01N/A
8/5/2008Q2 2008$0.02$0.04$0.04N/A
4/29/2008Q1 2008($0.04)$0.02$0.02N/A
2/26/2008Q4 2007$0.04$0.03$0.03N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.